Renal Cancer - Results from #40

Neglected Lymph Nodal Metastases in Patients with Renal Cancer: When to Extend the Anatomical Template of Lymph Node Dissection During Nephrectomy - Beyond the Abstract July 25, 2023

Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma - Beyond the Abstract July 24, 2023

Point of Care Parenchymal Volume Analyses to Estimate Split Renal Function and Predict Functional Outcomes After Radical Nephrectomy - Beyond the Abstract June 13, 2023

Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma - Beyond the Abstract June 6, 2023

The Changing Landscape of Immunotherapy for Advanced Renal Cancer - Beyond the Abstract May 24, 2023

Expression of RSUME is Associated With Poor Prognosis in Clear Cell Renal Carcinoma: Involvement of ROS Related Metabolism - Beyond the Abstract May 23, 2023

Comprehensive Management of Renal Masses in Solitary Kidneys - Beyond the Abstract May 16, 2023

Cost Effectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma - Beyond the Abstract April 26, 2023

The Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment in Renal Cell Carcinoma (RCC): A Systematic Review and Meta-Analysis - Beyond the Abstract April 20, 2023

Thermal Ablation vs. Active Surveillance for Renal Masses: a Systematic Review and Network Meta-analysis - Beyond the Abstract April 18, 2023

Trends of Kidney Cancer Burden From 1990 to 2019 in European Union 15 + Countries and World Health Organization Regions - Beyond the Abstract April 3, 2023

Efficacy and Safety of Vorolanib plus Everolimus in Metastatic Renal Cell Carcinoma: A Three-Arm, Randomised, Double-Blind, Multicentre Phase III Study (CONCEPT) - Beyond the Abstract March 28, 2023

Radical Cystectomy and Urinary Diversion Outcomes in Patients with Single vs. Double Renal Unit: A 2:1 Matched-Pair Analysis - Beyond the Abstract March 28, 2023

Expression of PD-L1 in Renal Cancer, Prognostic Features and Clinical Utility of Its Routine Staining - Beyond the Abstract March 27, 2023

Incidence of Benign Renal Masses in a Contemporary Cohort of Patients Receiving Partial Nephrectomy for Presumed Renal Cell Carcinoma - Beyond the Abstract March 21, 2023

Oncocytoma on Renal Mass Biopsy: Is It Still the Same Histology When Surgery Is Performed? Results from UroCCR-104 Study - Beyond the Abstract February 28, 2023

Progression-free Survival after Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations - Beyond the Abstract February 1, 2023

Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time? - Beyond the Abstract January 23, 2023

Nivolumab plus Ipilimumab plus Cabozantinib Triplet Combination for Patients with Previously Untreated Advanced Renal Cell Carcinoma: Results from a Discontinued Arm of the Phase III CheckMate 9ER Trial - Beyond the Abstract January 19, 2023

RE-VASC: An Adjuvant Scoring System in Diagnosis and Treatment of Renal Cell Carcinoma - Beyond the Abstract January 10, 2023

Page 3 of 16